431 related articles for article (PubMed ID: 12640112)
1. The Delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations.
Westfall MD; Mays DJ; Sniezek JC; Pietenpol JA
Mol Cell Biol; 2003 Apr; 23(7):2264-76. PubMed ID: 12640112
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of transcriptional repression of cell-cycle G2/M promoters by p63.
Testoni B; Mantovani R
Nucleic Acids Res; 2006; 34(3):928-38. PubMed ID: 16473849
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the expression pattern of p63 alpha and delta Np63 alpha in benign and malignant oral epithelial lesions.
Nylander K; Coates PJ; Hall PA
Int J Cancer; 2000 Aug; 87(3):368-72. PubMed ID: 10897041
[TBL] [Abstract][Full Text] [Related]
4. P63 alpha mutations lead to aberrant splicing of keratinocyte growth factor receptor in the Hay-Wells syndrome.
Fomenkov A; Huang YP; Topaloglu O; Brechman A; Osada M; Fomenkova T; Yuriditsky E; Trink B; Sidransky D; Ratovitski E
J Biol Chem; 2003 Jun; 278(26):23906-14. PubMed ID: 12692135
[TBL] [Abstract][Full Text] [Related]
5. Complex transcriptional effects of p63 isoforms: identification of novel activation and repression domains.
Ghioni P; Bolognese F; Duijf PH; Van Bokhoven H; Mantovani R; Guerrini L
Mol Cell Biol; 2002 Dec; 22(24):8659-68. PubMed ID: 12446784
[TBL] [Abstract][Full Text] [Related]
6. p53 associates with and targets Delta Np63 into a protein degradation pathway.
Ratovitski EA; Patturajan M; Hibi K; Trink B; Yamaguchi K; Sidransky D
Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1817-22. PubMed ID: 11172034
[TBL] [Abstract][Full Text] [Related]
7. p63 and p73 transactivate differentiation gene promoters in human keratinocytes.
De Laurenzi V; Rossi A; Terrinoni A; Barcaroli D; Levrero M; Costanzo A; Knight RA; Guerrieri P; Melino G
Biochem Biophys Res Commun; 2000 Jun; 273(1):342-6. PubMed ID: 10873608
[TBL] [Abstract][Full Text] [Related]
8. The Hay Wells syndrome-derived TAp63alphaQ540L mutant has impaired transcriptional and cell growth regulatory activity.
Lo Iacono M; Di Costanzo A; Calogero RA; Mansueto G; Saviozzi S; Crispi S; Pollice A; La Mantia G; Calabrò V
Cell Cycle; 2006 Jan; 5(1):78-87. PubMed ID: 16319531
[TBL] [Abstract][Full Text] [Related]
9. SSRP1 functions as a co-activator of the transcriptional activator p63.
Zeng SX; Dai MS; Keller DM; Lu H
EMBO J; 2002 Oct; 21(20):5487-97. PubMed ID: 12374749
[TBL] [Abstract][Full Text] [Related]
10. Retinoic acid inhibits downregulation of DeltaNp63alpha expression during terminal differentiation of human primary keratinocytes.
Bamberger C; Pollet D; Schmale H
J Invest Dermatol; 2002 Jan; 118(1):133-8. PubMed ID: 11851886
[TBL] [Abstract][Full Text] [Related]
11. Impaired Delta Np63 expression associates with reduced beta-catenin and aggressive phenotypes of urothelial neoplasms.
Koga F; Kawakami S; Kumagai J; Takizawa T; Ando N; Arai G; Kageyama Y; Kihara K
Br J Cancer; 2003 Mar; 88(5):740-7. PubMed ID: 12618884
[TBL] [Abstract][Full Text] [Related]
12. A subset of tumor-derived mutant forms of p53 down-regulate p63 and p73 through a direct interaction with the p53 core domain.
Gaiddon C; Lokshin M; Ahn J; Zhang T; Prives C
Mol Cell Biol; 2001 Mar; 21(5):1874-87. PubMed ID: 11238924
[TBL] [Abstract][Full Text] [Related]
13. p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes.
Dohn M; Zhang S; Chen X
Oncogene; 2001 May; 20(25):3193-205. PubMed ID: 11423969
[TBL] [Abstract][Full Text] [Related]
14. Evolution of functions within the p53/p63/p73 family.
De Laurenzi V; Melino G
Ann N Y Acad Sci; 2000; 926():90-100. PubMed ID: 11193045
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of transcription and induction of programmed cell death by human p53-family members p63 and p73.
Dietz S; Rother K; Bamberger C; Schmale H; Mössner J; Engeland K
FEBS Lett; 2002 Aug; 525(1-3):93-9. PubMed ID: 12163168
[TBL] [Abstract][Full Text] [Related]
16. Effects of p51/p63 missense mutations on transcriptional activities of p53 downstream gene promoters.
Kato S; Shimada A; Osada M; Ikawa S; Obinata M; Nakagawara A; Kanamaru R; Ishioka C
Cancer Res; 1999 Dec; 59(23):5908-11. PubMed ID: 10606233
[TBL] [Abstract][Full Text] [Related]
17. Itch/AIP4 associates with and promotes p63 protein degradation.
Rossi M; De Simone M; Pollice A; Santoro R; La Mantia G; Guerrini L; Calabrò V
Cell Cycle; 2006 Aug; 5(16):1816-22. PubMed ID: 16861923
[TBL] [Abstract][Full Text] [Related]
18. A C-terminal inhibitory domain controls the activity of p63 by an intramolecular mechanism.
Serber Z; Lai HC; Yang A; Ou HD; Sigal MS; Kelly AE; Darimont BD; Duijf PH; Van Bokhoven H; McKeon F; Dötsch V
Mol Cell Biol; 2002 Dec; 22(24):8601-11. PubMed ID: 12446779
[TBL] [Abstract][Full Text] [Related]
19. Loss of p63 expression is associated with tumor progression in bladder cancer.
Urist MJ; Di Como CJ; Lu ML; Charytonowicz E; Verbel D; Crum CP; Ince TA; McKeon FD; Cordon-Cardo C
Am J Pathol; 2002 Oct; 161(4):1199-206. PubMed ID: 12368193
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of p63 isoforms in normal tissues and neoplastic cells.
Nylander K; Vojtesek B; Nenutil R; Lindgren B; Roos G; Zhanxiang W; Sjöström B; Dahlqvist A; Coates PJ
J Pathol; 2002 Dec; 198(4):417-27. PubMed ID: 12434410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
